Evaluation of surgical-site infections following cardiovascular surgery.
Coskun
Diler
D
Aytaç
Jale
J
Deveci
Seda
S
Sönmez
Emine
E
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000453:epidemiology* / Q000401:mortality; D013504:Cardiovascular Surgical Procedures / Q000009:adverse effects*; D005260:Female; D006784:Hospitals, Teaching / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D016712:Mupirocin / Q000494:pharmacology; D012307:Risk Factors; D018571:Sentinel Surveillance; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000401:mortality; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D013530:Surgical Wound Infection / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality; D014421:Turkey / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D016712:Mupirocin